INTRODUCTION: Cancer tissue is composed of various stromal cells forming cancer-specific microenvironments. Peritumoral stroma is reportedly composed of activated fibroblasts that can influence the biological properties of tumor cells, mainly their local aggressiveness and their ability. The aim of this study was to examine whether the histological properties of peritumoral stroma are correlated with squamous cell carcinoma (SqCC) aggressiveness and clinical outcome. METHODS: A series of 220 pathological stage I lung SqCC were categorized into two types according to the histological properties of the peritumoral stroma, "fibrous stroma type" (n = 85), and "thin stroma type" (n = 135), and compared the prognostic significance. Furthermore, we compared the immunohistochemical properties of the SqCC cells surrounded by "fibrous stroma" with those of the SqCC cells surrounded by "thin stroma." RESULTS: The prognosis of the patients with fibrous stroma-type tumors was significantly poorer than that of the thin stroma type with regard to both recurrence-free survival (p = 0.005) and overall survival (p = 0.008). A multivariate analysis showed that the presence of a fibrous stroma was an independent prognostic factor (p = 0.030). Compared with the SqCC cells with a thin stroma, the SqCC cells with a fibrous stroma exhibited reduced expression of E-cadherin (55.9 versus 126.0, p < 0.001) and an increased expression of laminin-5γ2 (94.6 versus 25.0, p = 0.001), matrix metalloproteinase-7 (26.0 versus 3.50, p = 0.009), and c-Met (64.0 versus 36.5, p = 0.033). CONCLUSION: SqCC with a fibrous stroma displayed higher invasive phenotype and were associated with a significantly poor prognosis. The current results suggest that the microenvironment created by both SqCC cells and the peritumoral fibroblasts may facilitate cancer aggressiveness.
INTRODUCTION:Cancer tissue is composed of various stromal cells forming cancer-specific microenvironments. Peritumoral stroma is reportedly composed of activated fibroblasts that can influence the biological properties of tumor cells, mainly their local aggressiveness and their ability. The aim of this study was to examine whether the histological properties of peritumoral stroma are correlated with squamous cell carcinoma (SqCC) aggressiveness and clinical outcome. METHODS: A series of 220 pathological stage I lung SqCC were categorized into two types according to the histological properties of the peritumoral stroma, "fibrous stroma type" (n = 85), and "thin stroma type" (n = 135), and compared the prognostic significance. Furthermore, we compared the immunohistochemical properties of the SqCC cells surrounded by "fibrous stroma" with those of the SqCC cells surrounded by "thin stroma." RESULTS: The prognosis of the patients with fibrous stroma-type tumors was significantly poorer than that of the thin stroma type with regard to both recurrence-free survival (p = 0.005) and overall survival (p = 0.008). A multivariate analysis showed that the presence of a fibrous stroma was an independent prognostic factor (p = 0.030). Compared with the SqCC cells with a thin stroma, the SqCC cells with a fibrous stroma exhibited reduced expression of E-cadherin (55.9 versus 126.0, p < 0.001) and an increased expression of laminin-5γ2 (94.6 versus 25.0, p = 0.001), matrix metalloproteinase-7 (26.0 versus 3.50, p = 0.009), and c-Met (64.0 versus 36.5, p = 0.033). CONCLUSION: SqCC with a fibrous stroma displayed higher invasive phenotype and were associated with a significantly poor prognosis. The current results suggest that the microenvironment created by both SqCC cells and the peritumoral fibroblasts may facilitate cancer aggressiveness.
Authors: Ying Xiong; Lindsay T McDonald; Dayvia L Russell; Ryan R Kelly; Katie R Wilson; Meenal Mehrotra; Adam C Soloff; Amanda C LaRue Journal: World J Stem Cells Date: 2015-03-26 Impact factor: 5.326
Authors: Xiaozheng Zhao; Kenneth E Huffman; Junya Fujimoto; Jamie Rodriguez Canales; Luc Girard; Guangjun Nie; John V Heymach; Igacio I Wistuba; John D Minna; Yonghao Yu Journal: J Am Soc Mass Spectrom Date: 2017-07-27 Impact factor: 3.109
Authors: Jennifer B Dennison; Maria Shahmoradgoli; Wenbin Liu; Zhenlin Ju; Funda Meric-Bernstam; Charles M Perou; Aysegul A Sahin; Alana Welm; Steffi Oesterreich; Matthew J Sikora; Robert E Brown; Gordon B Mills Journal: Clin Cancer Res Date: 2016-05-12 Impact factor: 12.531
Authors: Y W Moon; G Rao; J J Kim; H-S Shim; K-S Park; S S An; B Kim; P S Steeg; S Sarfaraz; L Changwoo Lee; Donna Voeller; E Y Choi; Ji Luo; D Palmieri; H C Chung; J-H Kim; Y Wang; G Giaccone Journal: Cell Death Differ Date: 2015-01-16 Impact factor: 15.828
Authors: Matthew R Ramsey; Catherine Wilson; Benjamin Ory; S Michael Rothenberg; William Faquin; Alea A Mills; Leif W Ellisen Journal: J Clin Invest Date: 2013-07-08 Impact factor: 14.808
Authors: Kyuichi Kadota; Jun-Ichi Nitadori; Kaitlin M Woo; Camelia S Sima; David J Finley; Valerie W Rusch; Prasad S Adusumilli; William D Travis Journal: J Thorac Oncol Date: 2014-08 Impact factor: 15.609
Authors: D Korbakis; A Dimitromanolakis; I Prassas; G J Davis; E Barber; K L Reckamp; I Blasutig; E P Diamandis Journal: Br J Cancer Date: 2015-07-16 Impact factor: 7.640